Description
GDC-6036 is a KRAS G12C covalent inhibitor.
| Product Unit Size | Cost | Quantity | Stock |
|---|
GDC-6036 is a KRAS G12C covalent inhibitor.
| Cas No. | 2417987-45-0 |
|---|---|
| Purity | ≥98% |
| Formula | C29H32ClF4N7O2 |
| Formula Wt. | 622.07 |
| IUPAC Name | 1-[(3S)-4-[7-[6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloro-8-fluoro-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one |
| Synonym | GDC6036 |
| Appearance | White powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Cascetta P, Marinello A, Lazzari C, et al. KRAS in NSCLC: state of the art and future perspectives. Cancers (Basel). 2022 Nov 4;14(21):5430. PMID: 36358848
CDK4/6 inhibitor.
AurKA/B inhibitor.
Peptide, cleavage product of proenkephalin; κO...
Synthetic ITC, erysolin analog.
Alkaloid compound originally found in Corydalis...
SV2A synaptic vesicle inhibitor.
A fungal metabolite that inhibits protein synth...
D-amino acid, incorporated into bacterial cell ...
Thiol derivative, antioxidant.
Endogenous steroid hormone, estriol precursor; ...
AR antagonist.
Inert clozapine analog, activates specialized G...
β2-adrenergic agonist.
NO donor; AR antagonist.
Diterpene found in tobacco plants and cigarette...
Benzamide; HDAC1 inhibitor.
GSK3 inhibitor.
Fluoroquinolone; topoisomerase IV, topoisomeras...
β2-adrenergic agonist.
AT1 antagonist.